24.08.2020 16:32:30
|
Stock Alert: ADMA Biologics Rises 24%
(RTTNews) - Shares of ADMA Biologics Inc. (ADMA) are higher by more than 24 percent or $0.62 in Monday's morning trade at $3.14.
U.S. stocks are rising on Monday, extending gains from Friday's record highs, after the U.S. Food and Drug Administration or FDA approved emergency use of blood plasma to treat hospitalized COVID-19 patients.
ADMA Biologics manufactures specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. The company also joined the CoVIg-19 Plasma Alliance in May and has been collecting plasma from COVID-19 convalesced patients. The CoVIg-19 Plasma Alliance has been established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19.
ADMA Biologics has traded in a range of $1.45 to $5.48 in the past 52 weeks.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ADMA Biologics Incmehr Nachrichten
06.11.24 |
Ausblick: ADMA Biologics mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
07.08.24 |
Ausblick: ADMA Biologics stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu ADMA Biologics Incmehr Analysen
Aktien in diesem Artikel
ADMA Biologics Inc | 16,02 | -3,67% |